Abstract
Introduction and rationale: Endometriosis affects 5-15% of women in the reproductive period and, in infertile women, the prevalence is approximately 30%. As with any health condition, the choice of therapy should be guided by the results of relevant outcomes evaluated preferably in clinical trials. Thus, it is essential that clinical trials identify clinically relevant outcomes and that t…